Table 4.
Laboratory analysis: mean ± SD at baseline and after 30 days.
| Variable | Measure | AS | PS | Pa | |||
|---|---|---|---|---|---|---|---|
| Baseline | 30 Days | Baseline | 30 Days | Baseline | 30 Days | ||
| White cells | 103 | 6.25 ± 1.787 | 6.25 ± 1.828 | 6.86 ± 1.288 | 6.97 ± 1.611 | Ns | Ns |
| Red cells | 106 | 4.77 ± 1.023 | 4.76 ± 0.986 | 5.05 ± 0.526 | 5.01 ± 0.614 | Ns | Ns |
| Platelets | 103 | 208 ± 73.6 | 209 ± 64.5 | 221 ± 81.6 | 224 ± 70.8 | Ns | Ns |
| Hemoglobin | g/100 mL | 14.2 ± 2.94 | 14.3 ± 2.96 | 14.6 ± 1.27 | 14.5 ± 1.51 | Ns | Ns |
| Hematocrit | % | 41.9 ± 8.44 | 41.2 ± 8.36 | 43.5 ± 3.03 | 42.3 ± 4.02 | Ns | Ns |
| Creatinine | mg/dL | 1.05 ± 0.232 | 0.97 ± 0.228 | 1.03 ± 0.157 | 0.95 ± 0.138 | Ns | Ns |
| GOT | UI | 25.0 ± 14.5 | 25.1 ± 12.10 | 22.2 ± 5.98 | 23.9 ± 5.90 | Ns | Ns |
| GPT | UI | 28.9 ± 20.73 | 28.7 ± 17.08 | 25.8 ± 13.95 | 27.7 ± 16.93 | Ns | Ns |
| Bilirubin (direct) | mg/dL | 0.28 ± 0.098 | 0.29 ± 0.092 | 0.28 ± 0.076 | 0.27 ± 0.042 | Ns | Ns |
| Bilirubin (total) | mg/dL | 0.85 ± 0.430 | 0.83 ± 0.427 | 0.79 ± 0.297 | 0.75 ± 0.229 | Ns | Ns |
AS = aldiamed® spray; PS = placebo spray; Pa = p-value of anova test; Ns = not statistically significant. (p > 0.05); GOT = Glutamic Oxaloacetic Transaminase; GPT = glutamic-pyruvic transaminase.